Items tagged with Access

The Medicines Patent Pool expands mandate to hepatitis C and tuberculosis treatment (post with simple image)

TB is the leading cause of death for people living with HIV and killed 1.5 million people globally in 2014 alone. TB treatment has become more complex, particularly with the emergence of multidrug-resistant strains of TB. The Medicines Patent Pool, the world’s only voluntary licensing mechanism in public health, will now work to ensure access to new treatments for drug-resistant and drug-susceptible TB.

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid (post with simple image)

As countries improve and scale up their diagnostic services, increasing number of patients with multidrug-resistant TB and extensively drug-resistant TB are identified. Bedaquiline and delamanid offer a real opportunity to improve the outcomes of these patients. After so many decades without new TB drugs the development of these two new medicines is an historic opportunity to gain ground in the fight against TB.

Uganda: Civil society calls for more HIV/AIDS, TB funding (post with simple image)

November 10, 2015 - Civil society organizations (CSOs) under their umbrella organization the National Forum of People Living with HIV/AIDS Network in Uganda (NAFOPHANU) have launched a campaign to challenge the government to ensure that the country does not run out of essentials drugs.

Urgent need to register quality generic versions of linezolid in South Africa (post with simple image)

TB advocates request that the South African Medicines Control Council prioritize registration of quality-assured versions of generic linezolid for the treatment of drug-resistant TB.

TAG: An activist’s guide to regulatory issues (post with simple image)

Ensuring fair evaluation of and access to tuberculosis treatment.

First new TB drugs in half a century reach just 2% of people who need them (post with simple image)

Médecins Sans Frontières calls for companies to make new drugs to treat drug-resistant TB, bedaquiline and delamanid, available and affordable.

Sanofi faces criticism at Lung Conference (post with simple image)

TB activists at the 46th Union World Conference on Lung Health demanded that pharmaceutical company Sanofi be held accountable for failing to provide life-saving products to people and children living with TB and drug-resistant TB in South Africa and across the world.

Urgent need to make linezolid available in South Africa at affordable price (post with simple image)

TB advocates urge pharmaceutical companies to register their respective linezolid products in South Africa and make them available at an affordable price.

Lancet Series on access to and sustainable effectiveness of antimicrobials (post with simple image)

The Lancet published a Series of five papers examining access to and sustainable effectiveness of antimicrobials.

Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis (post with simple image)

Introducing bedaquiline and delamanid in TB programs worldwide has not kept pace with the need for these drugs. Coordinated global action might help assist making these medications accessible for persons who need them most.

Page 42 of 47 · Total posts: 0

←First 41 42 43 Last→